SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 27 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $42,630,000 | +2131400.0% | 11,498,000 | +1149700.0% | 0.01% | – |
| Q4 2014 | $2,000 | -99.3% | 1,000 | -98.9% | 0.00% | – |
| Q3 2014 | $302,000 | +3675.0% | 90,000 | +2900.0% | 0.00% | – |
| Q2 2014 | $8,000 | 0.0% | 3,000 | -25.0% | 0.00% | – |
| Q1 2014 | $8,000 | +33.3% | 4,000 | +33.3% | 0.00% | – |
| Q4 2013 | $6,000 | +20.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2013 | $5,000 | -99.9% | 3,000 | -99.9% | 0.00% | -100.0% |
| Q2 2013 | $3,353,000 | – | 2,202,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $431,748,000 | 6.08% |
| SYMPHONY ASSET MANAGEMENT LLC | 12,727,000 | $25,040,000 | 1.83% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,000,000 | $41,318,000 | 0.49% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,184,000 | 0.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 200,000 | $395,000 | 0.04% |
| Citadel Advisors | 11,000,000 | $21,696,000 | 0.03% |
| PEAK6 Group LLC | 15,000 | $2,951,000 | 0.02% |
| FRANKLIN RESOURCES INC | 17,290,000 | $34,071,000 | 0.02% |
| LORD, ABBETT & CO. LLC | 3,243,000 | $6,397,000 | 0.01% |
| EULAV Asset Management | 123,000 | $242,000 | 0.01% |